cagrilintide phase 3 Novo Nordisk presents data for next-generation Cagrilintide–semaglutide (CagriSema) as an add-on

Neuroprotection Research: Emerging gut-brain axis investigations: pro-inflammatory cytokine reduction in hippocampus, neuronal integrity preservation after trauma, dopaminergic and serotonergic system interactions, behavioral studies in rodent models

Long-term data beyond 12 weeks in humans does not exist from controlled trials

If we dont resupply our bodies with those essential nutrients, the systems that require vitamin B to function efficiently (ahem, metabolism) will suffer

The human evidence is close to zero

Key Research Properties: Small molecule NNMT (nicotinamide N-methyltransferase) inhibitor Modulates NAD+ metabolism and methylation capacity Studied in context of energy expenditure and metabolic regulation NNMT is upregulated in obesity